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Patients don’t have an ‘‘individual risk’’ or unique probabil-
ity of an outcome. Outside Mendelian inheritance, risks are
conditional probabilities and differ as the risk factors
included differ, at times substantially. This lack of reliability
is an inherent limitation and is not resolved by including
additional risk factors. Groups of like individuals need to
be assembled to measure the probability of an outcome.
Many groups, like any individual, can be identified, eg,
groups of the same age, sex, race, or any combination of
these attributes (or any others). That each of these groups
may have different risk means there is no such thing as
individual risk. This issue was identified by John Venn in
1866 and is known as the reference class problem. Models
relate risk factors to outcomes in populations. The number
calculated for an individual should not be reported as their
individual or true risk, nor should it be used as the sole cri-
terion for clinical decisions. Instead, Feinstein proposed
relying on clinically important subgroups. An example
would be utilizing an individual’s blood pressure as the pri-
mary determinant of hypertension treatment decisions, not
an unreliable individual risk estimate. J Clin Hypertens
(Greenwich). 2012;14:261–264. 2012 Wiley Periodicals, Inc.
The Framingham Heart Study played a key role in
identifying risk factors for coronary artery disease,
and Framingham investigators coined the term fac-
tors of risk.1 Logistic regression was developed to
analyze the epidemiologic data from Framingham.2
By 1973, the logistic regression model included sex,
age, cigarette smoking, blood pressure, serum choles-
terol, glucose tolerance, and electrocardiography (left
ventricular hypertrophy). Based on this model, the
American Heart Association published the Coronary
Risk Handbook: Estimating Risk of Coronary Heart
Disease in Daily Practice.3 It stated: ‘‘The purpose
of this Handbook is to provide the physician with a
method for easily estimating risk of coronary heart
disease in patients who have no clinical evidence of
coronary heart disease, and for guiding his choice of
preventive management.’’ The handbook included
tables that presented the 6-year risk of coronary
heart disease for individuals based on their risk fac-
tors. It contained a caution: ‘‘The figures given in
the tables should be taken only as guides to risk.
They are accurate estimates of group experience but
not necessarily the experience of any individual.’’
The publication of this handbook represents an his-
toric bench-to-bedside transition. An epidemiologic
research method associating risk with specific risk
factors in populations became a clinical method pro-
viding risk estimates for individuals. During the past
40 years, individual risk estimation has been broadly
accepted in medicine.
DISCORDANCE OF INDIVIDUAL RISK
ESTIMATES
There is much evidence that comparable risk stratifica-
tion methods give different individual risk estimates.
In a classic paper that has been ignored, Lemeshow
and colleagues4 evaluated 3 different methods for pre-
dicting hospital mortality in a large cohort of intensive
care unit patients. All 3 methods were comparable in
terms of calibration and discrimination; however, a
scatter plot (Figure) of the predicted risk for 2 of the
methods showed an astounding amount of discordance
between the individual risk estimates. The other 2
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FIGURE. Scatterplot of probability of hospital mortality from
APACHEII and MPMII24. Reproduced with kind permission from Leme-
show et al.4
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scatter plots were described as similar. Other examples
of the discordance of individual risk estimates can be
found in a recent review5 and analysis.6
More recently, understanding the discordance of
individual risk estimates has become important for
interpreting reclassification analysis. In this approach, 2
predictive models are compared after separating patients
into risk categories considered clinically important and
cross-tabulating the results for the 2 models. When the
predictions are discordant, individuals will be assigned
to different categories by the different methods. The dif-
ferent assignments are often interpreted as evidence that
one model is superior, rather than that different predic-
tors give different predictions.
Discordance can be produced by differences in accu-
racy or discrimination. Thus, accuracy and discrimina-
tion need to be assessed to interpret discordance. It
makes little sense to evaluate discordance when mod-
els are inaccurate. The discordance depicted by Leme-
show and colleagues did not reflect differences in
accuracy or discrimination.
THE CONCEPT OF INDIVIDUAL RISK
Risk is the probability of an undesirable outcome.
Individual risk is the probability an individual will
experience an undesirable outcome. However, an indi-
vidual either does or does not experience an undesir-
able outcome, so risk can never be determined for an
individual. In spite of this, it is assumed that a unique
probability, a true risk, of an undesirable outcome for
an individual exists. From this perspective, different
models used in the clinic to calculate individual risks
are estimating this unknown true risk with some error.
Pepe7 has dismissed the concept of true risk as having
‘‘major scientific problems’’ and as ‘‘interesting’’ but
‘‘nebulous.’’8
Scientifically there is no reason to believe that a
unique probability or true risk of an undesirable out-
come in an individual exists. That is only plausible
when some simple physical process is involved, such
as flipping a coin. The probabilities of Mendelian
inheritance, resulting from the segregation of chromo-
somes, are likely the only such probabilities encoun-
tered in medicine.8
Since risk cannot be measured in an individual,
there is no way to experimentally verify any of the
individual predictions provided by a model. This can
only be achieved by assembling a group of patients
like the individual. But there are many groups like an
individual that can be identified, eg, groups of the
same age, sex, race, or any combination of these attri-
butes (or any others). That each of these groups can
have different probabilities of an outcome means a
unique individual risk cannot be defined. This issue
was identified by John Venn as early as 1866 and is
known as the reference class problem.5 Von Mises9
gave an example for the probability of death. From
experience, life insurance companies knew that 0.011
of 40-year-old men who passed a medical examination
and were issued insurance would die in the next year.
But he described it as ‘‘utter nonsense’’ to say any
individual had a 0.011 probability of dying. For a
group of 40-year-old men and women, a lower proba-
bility would be expected and any 40-year-old man
belongs in this combined sex group as much as in the
single sex group. And he could be included in a large
number of other groups that would have yet other
probabilities of death.
It is important to recognize that even if all known
(and unknown) risk factors were to be included in a
risk stratification model, it would be more discriminat-
ing (and perhaps more useful clinically), but the result-
ing individual risk estimates would not become true
risks.
MODELS
Models were developed for research on disease in pop-
ulations. Essentially they assign risks to subgroups
defined by the included predictors. This risk stratifica-
tion of a population may be useful for efficiently allo-
cating resources within a population. For example, the
2 methods of predicting intensive care unit (ICU) mor-
tality discussed previously provide equivalent risk
stratification of the patient population. That is, each
assigns a similar fraction of the patient population to
different risk strata. Thus, if economic considerations
supported treating only patients above a given level of
risk, either method could be used. Even though each
method assigns the same fraction of the patient popu-
lation to the high-risk subgroup, the compositions of
the high-risk subgroups differ. As a result, some indi-
viduals assigned treatment by one method would be
denied treatment by the other.
But it is a mistake to use terms such as ‘‘individual
risk’’ or ‘‘true risk’’ for the number we calculate from
a risk model. Calling them event frequencies would be
preferable.
Mathematically inferior models produce subgroups
of near-average risk, while mathematically superior
models produce subgroups with widely varying risks.
This discrimination is a function of the number and
potency of included predictors. The commonly used
metrics of discrimination, the c-statistic and receiver
operating characteristic curve area under the curve,
reflect this dispersion. More discriminating models
producing broader risk distributions may be advanta-
geous for clinical use.
The potential benefit of adding new risk factors (eg,
coronary artery calcium) to an existing model (eg, Fra-
mingham risk model) is a model producing a broader
risk distribution.10 But assuming both models correctly
assign risk, the rank order of individuals in the popu-
lation cannot be maintained. This is because a group
of individuals that was correctly assigned a 12% risk,
for example, cannot subsequently be correctly assigned
a 15% risk. The benefit of improving the population
risk stratification is achieved at the cost of shuffling
the rank order of the individuals in the population.
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This redistribution is even seen when discrimination is
not improved. Mihaescu and associates10 characterize
this as ‘‘an updated model, compared with the addi-
tional model, simply makes different errors, not fewer
errors.’’
DISCUSSION
The key points that there is no such issue as individual
risk and that different predictors give different predic-
tions have been made previously by the Framingham
investigators: ‘‘It must be understood that there is no
such thing as an unconditional probability of cardio-
vascular disease developing, nor any conditional prob-
ability that may not alter if other factors are entered
into consideration.’’11
It is said that a man with one watch knows what
time it is, while a man with two watches is never sure.
If models are understood to generate individual risk
estimates, discordance presents a dilemma for the cli-
nician. Assuming both models are accurate, then their
estimates are equally valid. The mathematic problem
of risk stratifying a population does not have a unique
solution.
This may become especially troublesome when
additional information is obtained sequentially as
individual risk estimates may rise or fall, producing
contradictory information and therapeutic recommen-
dations.12
It is important to recognize the origin of these dif-
ferences and not misinterpret their importance. For
example, the observation that some individuals in
intermediate-risk categories, as estimated by Framing-
ham risk models, may be in low- or high-risk catego-
ries, as estimated by other methods, is expected and
by itself has no importance. Yet this reclassification
has been interpreted as meaningful and was used as a
criterion in a recent assessment of the clinical utility of
emerging risk factors.13
A number of approaches to the problem of discor-
dant risk estimates might be or have been proposed.
One option would be to only use a single method,
avoiding the generation of discordant individual risk
estimates. The perceived inadequacies of current meth-
ods do not provide a justification for obtaining addi-
tional estimates. Although current methods may omit
one or more risk factors, they may be perfectly ade-
quate for risk-stratifying a population. If newer meth-
ods including additional risk factors significantly
improve discrimination at reasonable cost, then they
could replace current methods. If a current method is
not accurate (calibrated) for some demographic or
population, it should be refitted (remodeled) or recali-
brated. A new method is not required to deal with this
problem. Finally, current methods may not identify
patients at low risk who will have events, but this is
an inherent limitation of probabilistic methods.
A second option would be to only add a new risk
marker ‘‘after adequate counseling of the patient of
the uncertain benefits and risks of reclassification, and
only if the patient and physician understand, discuss,
and are amenable to the treatment implications of risk
reclassification.’’14
A third option would be to average the discordant
individual risk estimates. However, the discordance
does not represent statistical variation around a ‘‘true’’
individual risk value and averaging will reduce the dis-
crimination provided by each of the models.
A fourth option is to provide the patient with the
discordant estimates.15 Clearly this would be confusing
to both patient and physician. An advantage of this
approach would be that patients and clinicians would
become familiar with the discordance of individual
risk estimates. If the discordant estimates were consid-
ered equally valid and lead to different preventive
measures, the patient could choose the preventive mea-
sure they preferred. These could range from taking a
statin, to taking tamoxifen, to having risk-reducing
breast surgery.
A fifth option for discordant estimates is to utilize
the highest probability estimate, as this ‘‘assigns a
final risk level based on the model that best
accounts for a client’s specific risk factor history.’’16
A concern with this approach is that each model
may be calibrated or accurate, but a policy of using
the maximum estimate may not. If enough models
are considered, too many individuals may end up
with above-average estimates, analogous to the fic-
tional Lake Wobegon, where all the children are
above average.
A sixth option would be to measure an additional
risk factor selectively in patients at intermediate risk
and, if the risk factor level is high, assign the individ-
ual to a higher-risk category.17 However, once a con-
tinuous risk estimate is developed, categorization
destroys information. Prior to the categorization, indi-
viduals at the upper and lower boundaries of a cate-
gory were readily differentiated, while individuals on
either side of a category boundary were understood to
be similar. Thus, if there were a simple method for
revising risk estimates based on the additional risk fac-
tor, it should be applied to the uncategorized risk esti-
mates. By only increasing estimates, this approach will
lead to a loss of accuracy via the Lake Wobegone
effect. Finally, it is difficult to justify revising only the
risk estimates of those at intermediate risk. A better
approach would be to use a multivariate method that
includes the additional risk factor. Kooter and col-
leagues18 have raised these points and importantly
demonstrated that there is no straightforward way to
update risk estimates.
Because the estimates depend on the model chosen,
Lemeshow and associates4 concluded that they should
not be used to make patient care decisions, eg, with-
drawing support from an ICU patient. A high-risk sub-
group identified by one model is just one possible
high-risk subgroup, not the only high-risk subgroup.
Thus, any such subgroup is not uniquely entitled to
treatment, such as a ventilator in a pandemic, ICU
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support, or an organ transplant. Clinicians who use
these models to make patient care decisions need to be
aware of their limitations.
Models relate included risk factors to outcomes in
populations. They are best understood to be providing
one of many possible risk stratifications of a popula-
tion, any of which may be useful for allocating
resources efficiently. However, the number calculated
for an individual should not be reported as their indi-
vidual or true risk, nor should it be used as the sole
criterion for clinical decisions.
Feinstein19 noted that individual risk estimates could
have ‘‘striking differences’’ and thus ‘‘that few clinical
prognosticators would want to make predictions’’
using them. ‘‘Instead, clinicians would want the
greater predictive ‘‘security’’ that is possible when the
individual forecasts are made from results in a perti-
nent ‘‘resemblance’’ subgroup.’’ Such an approach
would be simpler to implement and would have the
appeal of aligning preventive treatments with risk fac-
tors. An example would be utilizing an individual’s BP
as the primary determinant of hypertension treatment
decisions, not an unreliable individual risk estimate.
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